---
title: "Innovative drugs and CRO concept stocks strengthen again, Sunshine Guojian Pharmaceutical rises over 10%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241918954.md"
description: "Sunshine Guojian Pharmaceutical rose over 10%, SDKX, Zhendong Pharmacy, HISOAR, Baotai, Fushine, and Haofan Bio rose over 5%, while Shutai Shen, Jinkai Biotechnology, and Kylin Pharmaceutical also followed suit"
datetime: "2025-05-27T02:00:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241918954.md)
  - [en](https://longbridge.com/en/news/241918954.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241918954.md)
generator: "portal-rs"
---

# Innovative drugs and CRO concept stocks strengthen again, Sunshine Guojian Pharmaceutical rises over 10%

Sunshine Guojian Pharmaceutical rose over 10%, SDKX, Zhendong Pharmacy, HISOAR, Baotai, Fushine, and Haofan Bio rose over 5%, while Shutai Shen, Jinkai Biotechnology, and Kelaiying also followed suit

### Related Stocks

- [002099.CN](https://longbridge.com/en/quote/002099.CN.md)
- [688336.CN](https://longbridge.com/en/quote/688336.CN.md)
- [300497.CN](https://longbridge.com/en/quote/300497.CN.md)
- [300158.CN](https://longbridge.com/en/quote/300158.CN.md)
- [688136.CN](https://longbridge.com/en/quote/688136.CN.md)
- [300204.CN](https://longbridge.com/en/quote/300204.CN.md)
- [301509.CN](https://longbridge.com/en/quote/301509.CN.md)
- [688177.CN](https://longbridge.com/en/quote/688177.CN.md)
- [06821.HK](https://longbridge.com/en/quote/06821.HK.md)
- [301393.CN](https://longbridge.com/en/quote/301393.CN.md)

## Related News & Research

- [The 10-year Treasury yield is breaking out and 5% could be just the beginning. Here's why that matters.](https://longbridge.com/en/news/297548327.md)
- [Trump announces Medicaid drug pricing deals with 9 firms](https://longbridge.com/en/news/297557074.md)
- [20:00 ETWuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion](https://longbridge.com/en/news/297441220.md)
- [Heidelberg Pharma, Huadong Medicine expand ADC collaboration to develop new drug candidates](https://longbridge.com/en/news/297291658.md)
- [Tianjin Development FY26 H1 profit attributable to owners falls 5.58% to HK$ 325.22 million; revenue slips 3.53% to HK$ 1.66 billion](https://longbridge.com/en/news/297300410.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**